Skip to Content

Interruption of endocrine therapy for pregnancy – New promising data presented at SABCS22

Breast cancer patients from the POSITIVE clinical trial, who interrupted endocrine therapy to pursue pregnancy did not experience worse short-term recurrence rates.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top